Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Alpha Glucosidase Inhibitors Market From 2025 to 2029?

The market for alpha glucosidase inhibitors has expanded robustly in the past few years. The market worth is projected to escalate from $4.52 billion in 2024 to $4.84 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The upsurge in the historic timeframe is linked to the rising prevalence of diabetes, expansion in consciousness of diabetes management, progressions in diabetes treatment methodologies, predilection for oral antidiabetic drugs, clinical investigation, and evidence-oriented medical practice.

The market for alpha glucosidase inhibitors is forecasted to experience substantial expansion in the coming years, reaching a worth of $6.49 billion in 2029 with a compound annual growth rate (CAGR) of 7.6%. The predicted growth during the forecasting period can be associated with factors such as focusing on early intervention, an increase in the aging population, worldwide health initiatives for regulating diabetes, and incorporation into combination treatments. Key trends projected in this period encompass patient-centered methods, targeting type 2 diabetes management, advancements in medication distribution technology, emerging markets and global expansion, as well as collaborations and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11880&type=smp

What Elements Are Contributing To Growth In The Alpha Glucosidase Inhibitors Market?

The alpha-glucosidase inhibitors market is poised for potential growth due to the rising global incidence of diabetes. This metabolic disease, characterized by elevated levels of blood glucose (or blood sugar), can lead to serious damages to the heart, blood vessels, eyes, kidneys and nerves if left unchecked. By inhibiting carbohydrate absorption in the small intestine, alpha-glucosidase inhibitors can regulate postprandial blood glucose concentrations and manage diabetes. In November 2022, the International Diabetes Federation, based in Belgium, reported that 1 out of every 10 adults worldwide, or 537 million people, suffer from diabetes. Furthermore, this figure is anticipated to rise to 643 million by 2030 and 783 million by 2045. As such, the increasing global prevalence of diabetes is a key factor driving the growth of the alpha-glucosidase inhibitors market.

Which Segments Are Detailed In The Global Alpha Glucosidase Inhibitors Market Report?

The alpha glucosidase inhibitors market covered in this report is segmented –

1) By Type: Dumping Syndrome, Type 2 Diabetes

2) By Drug Class: Acarbose, Miglitol, Voglibose

3) By Constituent: Glucoamylase, Isomaltase, Maltase, Sucrase

4) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

Subsegments:

1) By Dumping Syndrome: Post-Gastric Surgery Management, Symptomatic Treatment

2) By Type 2 Diabetes: Monotherapy, Combination Therapy

What Upcoming Trends Are Expected To Impact The Alpha Glucosidase Inhibitors Market Globally?

The ascendency of product innovation is one notable trend in the alpha-glucosidase inhibitors market. To consolidate their market position, principal firms within the alpha-glucosidase inhibitors industry are focusing on the creation of novel products. For example, TheracosBio, an American pharmaceutical company, in January 2023, earned the U.S. Food and Drug Administration’s (FDA) approval for Brenzavvy (bexagliflozin); a distinctive oral inhibitor of sodium-glucose cotransporter 2 (SGLT2), designed to treat adults diagnosed with type 2 diabetes. Brenzavvy is recommended as an accompaniment to diet and exercise routines, facilitating individuals with type 2 diabetes to effectively control their blood sugar levels by prompting the kidneys to eliminate sugar via urine.

Who Are The Key Contributors To Growth In The Alpha Glucosidase Inhibitors Market?

Major companies operating in the alpha glucosidase inhibitors market include Bayer AG, Merck & Co., Alkem Laboratories Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Lupin Ltd., Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company, Torrent Pharmaceuticals Ltd., Unichem Laboratories Ltd., Pfizer Inc., Boehringer Ingelheim International GmbH, AstraZeneca PLC, Mitsubishi Tanabe Pharma Corporation, Eli Lilly and Company, Johnson & Johnson, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., Hanmi Pharmaceuticals Co., Ltd., Eisai Co., Ltd., Biocon Limited, Cadila Pharmaceuticals Ltd

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/alpha-glucosidase-inhibitors-global-market-report

Which Region Is Projected To Lead The Alpha Glucosidase Inhibitors Market By 2025?

North America was the largest region in the alpha glucosidase inhibitors market in 2024. Middle-East is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha glucosidase inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11880&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model